Spire Wealth Management Nevro Corp Transaction History

Spire Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$40.85 - $77.67 $2,246 - $4,271	-55 Reduced 35.48%	100 $4,000
Q4 2021 Jan 14, 2022	SELL	$81.07 - $121.29 $9,079 - $13,584	-112 Reduced 41.95%	155 $13,000
Q3 2021 Oct 22, 2021	SELL	$101.99 - $166.36 $16,216 - $26,451	-159 Reduced 37.32%	267 $31,000
Q1 2021 May 21, 2021	BUY	$132.81 - $182.18 $56,577 - $77,608	426 New	426 $59,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.